Press
See Our Recent Ad in In Vivo Magazine
Healogix offers services to help biotech companies achieve maximum valuation…Click here to see the advertisement. ...
September 24th, 2009 Read MoreHarris Kaplan to Present at Bio2Device Group Dec. 8, 2009
Topic: “Science + Commercialization = Valuation. Building a Commercial Story that Resonates with Prospective Partners.” Speaker: Harris Kaplan, President and Chief Executive Officer, Healogix Date and Time: Tuesday, Dec.. 8, 2009, 6:00 – 9:00 pm Location: Location: TIPS Group Law ...
September 15th, 2009 Read MoreHarris Kaplan Featured in BioWorld Today
Healogix CEO Harris Kaplan was featured in the August 14, 2009, issue of BioWorld Today. Kaplan discussed the growing interest in patient-reported outcome instruments, which are increasingly becoming a critical component of all phases of a drug’s life cycle. Yet while PROs are popping up in everything from oncology to gastrointestinal therapy, the subjective endpoint tools are still difficult to refine for reliability. To read the article please click here ...
August 20th, 2009 Read MoreHealogix plays a role in $350M Bayhill – Genentech deal
Paul Westberg, VP of Business Development for Bayhill Therapeutics, wrote “I am pleased to say that all of the hard work by everyone who has contributed to the program, including Healogix, has resulted in a premier partnership with Genentech / Roche. Thanks for all of your recent work on this project.” Click here to view an article “Bayhill Therapeutics Snags $350M Deal with Genentech” in BioWorld Today. ...
July 2nd, 2009 Read MoreHarris Kaplan to Speak at BioScience Forum June 17th
Harris Kaplan presents “Crossing the Biotech-Pharma Chasm”. Click here to download this presentation. (PDF Format) ...
June 25th, 2009 Read MoreHealogix CEO Harris Kaplan spoke at the MRA Conference
Healogix CEO Harris Kaplan spoke at the MRA Conference, presenting on “How Pharma Marketing Research Is Changing.” Click Here to download his presentation. (PDF Format) ...
June 5th, 2009 Read MoreHarris Kaplan Reflects on Future of Obesity Market in “The Pink Sheet”
Healogix CEO Harris Kaplan discusses the future of drug development for obesity in the June 1 issue of “The Pink Sheet.” If you would like to read the article please click on the link below. You will need to be a current subscriber of the “The Pink Sheet”. http://www.thepinksheet.com/fdcreports/story/viewStory.do?targetAN=00710220009 ...
June 2nd, 2009 Read MoreTim Edbrooke Joins Healogix
Tim’s pharmaceutical career spans 20 years and an impressive array of disciplines from clinical development through to the commercialization of products and general management. At Healogix he is responsible for developing and implementing all aspects of our client engagement process, ensuring that we create highly effective partnerships with our clients that help drive their businesses forward. ...
March 6th, 2009 Read MorePMRG Conference: March 2009
Tim O’Rourke will co-present with Ram Ramgopal, CEO of VRT, at the upcoming Pharmaceutical Marketing Research Group conference March 8-10, 2009. ...
February 19th, 2009 Read MoreTim O’Rourke Appointed to PMRG Executive Board
PMRG announced today the appointment of Tim O’Rourke to the Executive Board. PMRG is an independent, voluntary, non-profit association whose purpose is ...
January 5th, 2009 Read MoreOffice: 215.863.8160 | Fax: 215.830.5051 | Email: info@healogix.com
Marketing Research and Consulting for the Pharma and Biotech Industries